This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Acquity Group Stockholders Seeking More Money, Information In Buyout Should Contact Deans & Lyons Law Firm

DALLAS, May 30, 2013 /PRNewswire/ -- Securities lawyers at Deans & Lyons announced an investigation of the board of Acquity Group Limited (NYSE: AQ) for a proposed sale to Accenture PLC valued at approximately $316 million. AQ investors are encouraged to contact attorney Hamilton Lindley at 877-819-8033 or hlindley@deanslyons.com about their rights and remedies.

Under the proposed sale, AQ shareholders will receive $13 in cash for each AQ share owned.  The potential shareholder action seeks to obtain more value for AQ stockholders through the disclosure of important information and ensuring the highest price reasonably available is obtained. 

The securities lawyers of Deans & Lyons have significant experience representing investors nationwide in representative actions involving securities at no cost to its clients.  Stockholders with concerns about this AQ stock or anyone with information about this acquisition should contact Hamilton Lindley at hlindley@deanslyons.com or 877-819-8033.

Hamilton LindleyDeans & Lyons LLP 325 N. Saint Paul Street, Suite 1500 Dallas, TX 75201 (877) 819-8033 Toll Free (214) 965-8500 Telephone (214) 965-8505 Facsimile  hlindley@deanslyons.com  deanslyons.com

SOURCE Deans & Lyons LLP

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs